Evidence map›Paper›PMID 28866749›Full record

ArticleEndocrine2017

The radiographically diagnosed adrenal myelolipoma: what do we really know?

Michael J Campbell, Mary Obasi, Bingling Wu, Michael T Corwin, Ghaneh Fananapazir

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Concurrent adrenal and extra-adrenal myelolipoma: A case report.International journal of surgery case reports · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. [Adrenal myelolipoma, review of the literature in Mexico apropos of two cases].Revista medica del Instituto Mexicano del Seguro Social · 2022
    Review
  14. Giant symptomatic adrenal myelolipoma: A case report.Annals of medicine and surgery (2012) · 2022
    Article
  15. Adrenal myelolipomas.The lancet. Diabetes & endocrinology · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael J CampbellDepartments of Surgery and Radiology, University of California, Davis Medical Center, Sacramento, CA, USA. mjcampb@ucdavis.edu.
Mary ObasiDepartments of Surgery and Radiology, University of California, Davis Medical Center, Sacramento, CA, USA.
Bingling WuDepartments of Surgery and Radiology, University of California, Davis Medical Center, Sacramento, CA, USA.
Michael T CorwinDepartments of Surgery and Radiology, University of California, Davis Medical Center, Sacramento, CA, USA.
Ghaneh FananapazirDepartments of Surgery and Radiology, University of California, Davis Medical Center, Sacramento, CA, USA.
University of California Davis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdrenal myelolipomas are uncommon, benign tumors of the adrenal glands that are not routinely evaluated for autonomous hormone secretion or followed by repeat imaging, but may lead to retroperitoneal hemorrhage. Little is known about the natural history these tumors with the majority of previous publications being confined to case reports and small case series.

methodsWe reviewed the computed tomography (CT) reports of 62,279 patients evaluated at a tertiary referral center between 2002 and 2015 for the presence of an adrenal myelolipoma >1 cm in size. We then reviewed the CT imaging and patient charts to determine tumor size, growth, evidence of retroperitoneal hemorrhage, and endocrine dysfunction.

resultsWe identified 150 (0.24%) patients with 155 radiographically diagnosed adrenal myelolipomas found on a CT scan during our study period. The median tumor size at discovery was 2.1 cm. Twelve (7.7%) tumors were >6 cm. Sixty-nine (46%) patients had a follow-up CT with a mean time interval between scans of 3.9 years. Eleven tumors (16%) grew over our follow-up period with a median growth rate of 0.16 cm/year. No patient developed a retroperitoneal hemorrhage. Twenty (13%) patients underwent an evaluation for endocrine dysfunction. Three patients had evidence of hypercortisolism and one patient had primary aldosteronism.

conclusionThe majority of radiographically diagnosed adrenal myelolipomas found on abdominal CT imaging are small and slow growing. Retroperitoneal hemorrhage is uncommon, but the rate of associated endocrine dysfunction may be underestimated.

Indexed as

Adrenal Gland NeoplasmsAdrenal GlandsAdultAgedAged, 80 and overFemaleHumansIncidental FindingsMaleMiddle AgedMyelolipomaTomography, X-Ray ComputedYoung AdultAdrenal incidentalomaAdrenal myelolipomaHypercortisolism

Identifiers

PMID28866749
OpenAlexW2753717726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.